Josh Levitsky, MD, MS is currently an Associate Professor of Medicine and Surgery in the Division of Gastroenterology & Hepatology at the Northwestern University Feinberg School of Medicine. Dr. Levitsky received his BS from the University of Michigan and MD from the Albert Einstein College of Medicine where he was elected to Alpha Omega Alpha. He then completed an Internal Medicine residency and Gastroenterology fellowship at the University of Chicago Hospitals and a Transplant Hepatology fellowship at the University of Nebraska Medical Center, receiving an AASLD Fellowship Award. At Northwestern, he completed a MS in Clinical Investigation. He is currently certified by the American Board of Internal Medicine in Gastroenterology and Transplant Hepatology.
Dr. Levitsky is an active member of several professional societies, including the American Society of Transplantation (AST), American Association for the Study of Liver Disease (AASLD), and International Liver Transplantation Society (ILTS). He has served on several committees and councils. Dr. Levitsky’s academic interests are clinical and translational in nature, with a focus on liver transplant immunosuppression, tolerance, and biomarkers. He previously received an AASLD Career Development Award in Liver Transplantation and has published numerous peer-reviewed journal articles, abstracts, book chapters and reviews on topics relevant to liver disease and transplantation. He is an Associate Editor for the American Journal of Transplantation. He is the principal and co-investigator for a number of NIH, pharmaceutical, and investigator-initiated trials. At Northwestern, he is currently the Gastroenterology and Transplant Hepatology Fellowship Program Director and Director of Liver Transplant Research. He has been elected to the Feinberg Academy of Medical Educators and has received several teaching awards.
Dr. Levitsky has been a longstanding active member of the AST since the early 2000s. From 2010 – 2013, he was a member of the ATC Program Planning Committee and was able to significantly impact the number and quality of the liver programs. He is currently on the ATC Executive Planning Committee, representing the AST as the Co-Chair and will be Chair in 2016-2017. In 2014, he was the recipient of the AST Clinical Science Investigator Award. Finally, he was elected to the AST Board of Directors in 2014 and serves as a Councilor-at-Large. In this role, he is currently leading an effort to provide a web-based curriculum for transplant trainees, called the AST Comprehensive Trainee Curriculum (CTC).
Updated February 2016